Although automobile driving is necessary for many people, including patients with mental disorders, the influence of psychotropic drugs on driving performance remains unclear and requires scientific verification. Therefore, the objective of this study was to conduct a review of the literature in order to aid the development of a valid evaluation method regarding the influence of medication on driving performance. We conducted a literature search using two sets of terms on PubMed. One set was related to psychotropic drugs, and the other to driving tests. We excluded reviews and case studies and added literature found on other sites. A total of 121 relevant reports were found. The experiments were roughly divided into on-the-road tests (ORT) and driving simulators (DS). Although highway driving tests in ORT are most often used to evaluate driving performance, DS are becoming increasingly common because of their safety and low cost. The validity of evaluation methods for alcohol should be verified; however, we found that there were few validated tests, especially for DS. The scenarios and measurement indices of each DS were different, which makes it difficult to compare the results of DS studies directly. No evaluation indices, except for SD of lateral position, were sufficiently validated. Although highway ORT are the gold standard, DS were shown to have an increasing role in evaluating driving performance. The reliability of DS needs to be established, as does their validation with alcohol in order to accumulate more high-quality evidence.
A UTOMOBILES ARE AN indispensable means of transportation in daily life in many countries and regions, especially in rural areas where public transportation is not sufficiently available. This is also true for people with mental disorders. About 70% of mentally disabled people have a driver's license, 80% of whom drive a car on a daily basis. 1 Meanwhile, it has been pointed out repeatedly that various diseases, including mental disorders, and the medications used to treat them, may affect driving performance. 2, 3 In the UK and Australia, criteria have been published for judging the driving suitability of patients with mental disorders. 4, 5 However, no criteria have been established regarding how to estimate sufficiently the influence of medications, such as psychotropic drugs. In the USA, which is seen as an automobile-centric country, drowsiness is thought to be the primary cause of 15-20% of all traffic accidents, and drowsiness, dizziness, and wobble can be caused by not only a variety of diseases, but also a variety of medications (e.g., opioids, antihistamines, benzodiazepines [BZD] , antidepressants) used as therapeutic agents. Therefore, countermeasures are strongly required. 6 The World Health Organization (WHO) also declared in 2004 that 'Road traffic injuries are a major but neglected global public health problem, requiring concerted efforts for effective and sustainable prevention'. 7 Among these efforts, reducing the number of traffic accidents associated with medications is positioned as a top priority in the context of public health. 7 It has been reported that the use of psychotropic drugs, such as BZD and tricyclic antidepressants, is associated with an increased risk of traffic accidents. 8 This risk has been reported repeatedly in epidemiological studies investigating the relation between traffic accidents and the use of gamma-aminobutyric acid (GABA) drugs, such as BZD. [9] [10] [11] In recent years, zolpidem, which is most commonly used as a hypnotic, has attracted attention because of a reported association between blood drug concentration and driving skills. 12 Therefore, the Food and Drug Administration (FDA) decided to halve the recommended starting dose 13 and declared their intention to assess the influence of hypnotics on driving skills.
14 Hypnotics other than GABA drugs, such as ramelteon 15 and suvorexant, 16 have also been reported to affect driving skills, and this finding played an important role in determining the starting dose of suvorexant. In 2015, the FDA pledged to evaluate the effect of drugs acting on the central nervous system (CNS) on driving performance, and announced a draft guidance regarding that evaluation. 17 However, because it targeted primarily pharmaceutical companies, only an outline of the general principles and targets of the survey was given, and no specific methodologies regarding the evaluation of driving performance were mentioned.
At present in Japan, almost all CNS drug inserts state that those taking the drug should not operate a motor vehicle. This is a big problem because it limits the social lives of patients substantially. Even if their symptoms are stabilized and they have recovered to a state in which social reversion is possible, it is impossible for them to drive unless they discontinue their medication. This may cause patients to lose opportunities for social reintegration depending on the content of their work or their commuting method. Furthermore, this may lead to nonadherence to treatment and even make it difficult to receive the necessary treatment because without being able to drive, simply visiting the hospital becomes an issue. Meanwhile, some countries (e.g., the USA and UK) seem to be taking a more realistic approach to driving under medication, and these approaches are attracting attention according to the influence of drugs. However, since information provision is not necessarily based on the evidence, information and warnings based on scientific verification are required both inside and outside the country. In Japan, no guidelines have been established regarding how to evaluate the effects of psychotropic drugs on driving ability, and determining an effective evaluation method with guidance only from the FDA is difficult. Based on the above, we carried out a review of the relevant literature to aid the development of a valid evaluation method regarding the influence of medication on driving performance.
METHODS

Literature search
We conducted an electronic search of the Englishlanguage literature published up to July 2017 on PubMed to identify methods of evaluating driving performance under psychotropic medication using two sets of search terms. The sets consisted of ' "psychotropic" OR "antidepressant" OR "hypnotic" OR "anxiolytic" OR "antipsychotic" OR "mood stabilizer" OR "anticonvulsant" OR "tranquilizer" OR "ataractic" ' AND ' "driving performance" OR "driving skills" OR "automobile driving" OR "driving fitness" OR "driving test" OR "on the road" OR "driving simulator".' Additional manual searches were carried out based on the references in the selected studies. Studies were judged as being relevant based on titles and abstracts. The inclusion criteria were: (i) an original research paper; (ii) evaluated driving performance with an actual automobile or a driving simulator (DS); (iii) evaluated driving fitness using a cognitive test battery; (iv) evaluated driving-related cognitive test using a steering wheel; (v) involved participants taking antidepressants, hypnotics, anxiolytics, antipsychotics, mood stabilizers, or anticonvulsants; and (vi) written in English. All articles included were read, and the study excluded review articles, commentaries, case studies, epidemiologic studies, studies in which the associated medication was not a psychotropic drug, and studies involving cognitive testing only, except for the computer-based Act and React Test system (ART-90), which is used to assess driving fitness.
RESULTS
Selection of studies
A total of 3118 abstracts were initially identified, 425 of which were review articles and therefore removed. Of the 2693 remaining articles, 2587 articles were removed for meeting the exclusion criteria. After the full texts were retrieved and reviewed to confirm that they met the inclusion criteria, 106 articles were deemed eligible for analysis. Fifteen additional articles were added from other sources. Therefore, the final sample at this stage was 121 articles (Fig. 1 ).
Evaluation method of driving
Currently, tests for evaluating driving are roughly divided into on-the-road tests (ORT) and laboratory tests that use ART-90 or a DS. Driving experiments are conducted in many countries, especially throughout Europe. More than half of the studies evaluating driving have been conducted in the UK and the Netherlands, followed by Germany and France. Driving aptitude equipment primarily consisting of multiple cognitive function tests (i.e., ART-90) has been used since around 1990, mainly in Germany, and it is still used for evaluations targeting patient groups today.
In total, 121 papers were classified as involving: actual vehicle tests for healthy subjects (Table 1 16, ), DS experiments for healthy subjects (Table 2 15,22, 50, 52, 56, ), actual vehicle experiments and DS experiments for patients (Table 3 44,58, ), and experiments using ART-90. Twenty-seven out of 121 studies targeted patients using real vehicles and DS. For ART-90, most of the subjects (11 of 12) were patients. When classifying the papers according to the evaluation method, 67 (55%) used ORT, 51 (42%) DS, and 12 (10%) ART-90.
ORT
The highway driving test (HDT) performed in the Netherlands was frequently used in ORT (40 studies 16, [20] [21] [22] [23] [24] [25] [26] [27] [28] 30, [33] [34] [35] [36] [37] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] 58, 63, 105, 107, 113, 114, 117, 120, 121, 123, 125 out of 67). In the HDT, the examiner sits in the 106 and the Wasserburger-Fahrverhaltensbeobachtung (WAFAB), 104 used in the USA and Germany, respectively, were also included as passenger-evaluated tests. In these tests, the subjects drive on a prescribed road while the passenger evaluates not only driving skills, but also complex driving abilities, such as attitude and attention during driving based on a predefined evaluation sheet.
DS
There are currently 36 types of confirmed DS. 15, 22, 50, 52, 56, [108] [109] [110] [111] 115, 116, 118, 119, 122, [126] [127] [128] As each research group uses a DS for a specific purpose, there is no unified scenario (e.g., highway, urban roads). Therefore, the task time ranges from 2.5-150 min, and DS come in various forms (e.g., PC-based, fixed-type car body, unfixed car body). Characteristics such as size and sounds also differ. The evaluation contents conform to an actual vehicle test, but different indices are measured for each DS. Consequently, there are a relatively large number of evaluation indexes for DS compared with ORT.
ART-90
ART-90 examines the minimum required performance capability for appropriate safe driving behavior (e.g., intelligence, perception, decision, reaction, attention). ART-90 consists of several types of test equipment and can be used as a test battery because it is the result of a consolidation of conventional tests. Therefore, it can judge driving suitability efficiently. ART-90 was developed in Austria, and is currently used in EU countries, such as Germany. It is mainly used for tests that target patient groups, and is regarded as a judgment index for driving aptitude in reference to standard values for healthy individuals. 31, 104, 109, 111, [129] [130] [131] [132] [133] [134] [135] [136] 
Study characteristics
Age and sex There tended to be a higher ratio of males to females in the experiments (50.6% vs 43.1% for ORT, 6.3% unknown; and 52.3% vs 28.9% for DS, 18.8% unknown, respectively). The ages of the participants ranged from 18 to 78 years, but only three of the 121 studies targeted individuals aged over 65 years. Most of the experiments targeted young people (the mean age of the total sample was 37.8 years).
Health status
The subjects were categorized into two groups: a healthy group and a patient group. Approximately 65% of the test subjects in ORT and DS were healthy, and more than 90% of the experiments were designed for healthy subjects. Conditions in the patient group were mostly insomnia, anxiety, and depression. The numbers of studies regarding each condition were eight on insomnia, five on anxiety, five on depression, two on bipolar disorder, and one on phobia. In ART-90 studies, six of eight studies were designed for schizophrenia.
Study drugs
The medications listed in Table 4 were studied as test drugs in the experiments. The frequency of drugs used as positive control in each test was especially high. The most commonly used drug was zopiclone. Because a significant deterioration of driving skill after ingestion has been recognized, 107 zopiclone was commonly used as a comparative control when investigating hypnotics. Amitriptyline, 114 which has also been shown to affect driving skill, was commonly used as a positive control for antidepressants. Recently, the number of studies involving mirtazapine, which is increasingly recognized as a positive control, has also increased. 30 However, studies on antipsychotic drugs, mood stabilizers, and antiepileptic drugs are scarce, and thus a topic for future research.
Measurements
SD of lateral position, mean lateral position
The SD of the lateral position (SDLP), which is the most commonly utilized measurement in the evaluation index, was used in 54 of 121 studies. 15, 16, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 30, [33] [34] [35] [36] [37] [38] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] 58, 63, [70] [71] [72] [73] [74] [75] [76] 79, 80, 105, 107, [113] [114] [115] [116] [117] 120, 121, 123 Four studies 75, 76, 84, 108 used similar evaluation indices without referencing SDLP. In HDT involving ORT, the subjects were tested for about 1-2 h while maintaining a speed between 95 km/h and 100 km/ h. At that time, they were instructed to maintain a constant position in the low-speed lane. The distance from the center line of the vehicle body measured every 5 km is the lateral position, the mean value is the mean lateral position (MLP), and the SD is the SDLP. 137 This measurement, which is said to be the most valuable, indicates road tracking errors and weaving. Although MLP is a control variable indicating whether the subject can perform the test as instructed, the effect of medication cannot be observed clearly, and the variability is smaller compared with SDLP. Even in DS, SDLP or a similar index is adopted, similar to ORT.
SD of speed, mean speed
The SD of speed (SDS) was used in 38 of 121 studies. 16, 18, 19, 24, [26] [27] [28] 30, 33, [35] [36] [37] 40, 43, 47, 52, 63, 70, 71, 74, 77, 78, 82, 86, 98, 100, 105, 107, 110, [113] [114] [115] [116] 120, 121, 124, 127, 128 The SDS is the mean and SD of vehicle speed measured in HDT, and is often used as a secondary measurement of SDLP. It is measured similarly in DS.
Inappropriate line crossing
Inappropriate line crossing (ILC) is the number of times the car body crosses over either the left or right line after the SDLP value has exceeded a certain level.
ILC was used in 11 of 121 studies, 15, 20, 22, 36, 37, 70, 71, 74, 99, 100, 114 including those showing similar concepts for convenience, even though these did not specifically designate the value as ILC. ILC is mainly used in DS, but also in ORT in countries other than the Netherlands. It is checked manually from the drive recorder images. Similar to the measurement of SDLP, line crossing is not counted when overtaking a car in the slow lane.
Reaction time, brake reaction time, and time to speed adaptation As it is assessed in various situations, reaction time (RT) measures a very diverse range of circumstances. Among these, brake reaction time (BRT; 14 of 67 studies) was used in BRT tests in ORT, and time to speed adaptation (seven of 67 studies) was used in car-following tests. BRT is the reaction time until stepping on the brake pedal in response to a stimulus presented during driving, and time to speed adaptation is the response time to decelerate the driver's vehicle in accordance with the deceleration of the leading vehicle. Similarly, in DS, 15 15, 56, 72, 73, 75, 77, 79, 80, 91, 98, 100, 118, 119, 122, 128 of 51 studies used BRT and 12 85, [87] [88] [89] [90] 93, 95, 96, 101, 116, 126, 128 of 51 studies used RT to stimulation.
Distance coefficient of variation
Distance coefficient of variation (DCV), which was measured in a DS by Iwamoto et al., 73, 79, 80 represents the variation in distance between the subject's vehicle and the preceding vehicle that accelerates and decelerates in the car-following test. DCV can evaluate driving skills using the inter-vehicle distance, which is difficult to measure in ORT, and has been studied in six studies 15, 72, 73, 75, 79, 80 to date.
Global rating, errors, and global scores
Global rating, errors, and global scores are used to evaluate driving skills objectively by an observer who rides in an experimental car. In the WAFAB, the observer scores six basic driving skills (e.g., lane, speed, crossing, reaction, distance, preparation) on a scale ranging from 1 to 6 (global rating). 104 In the WURT, nine categories composed of 54 error items are evaluated in three grades. 138 In other ORT, 125 ,127 the passengers evaluate checklists of 100 items or more, while in DS tests, driving attitude and behavior are evaluated based on global scores, and errors, such as accidents in scenarios, are counted.
Recent trends
Because of space limitations, it is impossible to present all the studies that were targeted in the present review. Some are historically positioned as evaluation methods and they are rarely used. Therefore, in the studies involving ORT and DS conducted over the last 10 years, we show the evaluation methods and indices of only 25 studies targeting healthy subjects (Table 5 15, 16, [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] 105, 112 ). Thirteen of these studies involved ORT, nine of which were conducted in the Netherlands, and 13 involved DS studies, six and four of which were conducted in Japan and France, respectively. SDLP was measured in almost all studies in both ORT and DS, but the other evaluation indices varied by country.
Stability of evaluation index
It is indispensable for a desirable evaluation method to have confirmed reliability and validity. To detect even small effects of medications and diseases, stable measurement data need to be obtained without being influenced by intraindividual and interindividual differences. In the present review, we focused on SDLP, which was measured in almost all tests, to examine the stability of data over the last 10 years, and then determined the coefficient of variation (CV) of SDLP when the subjects were administered a placebo as a control. As a result, the CV was largely between 15% and 30%. Although the experimental design was different in each study, a CV within 30% of SDLP is thought to be a standard for data stability. This could be not only an index of stability, but also an element that affects reliability and validity because of its usefulness in determining the measurement time to acquire stable data.
Reliability
If individual variation in the evaluations is large, it is impossible to evaluate the effect of medication on driving skills appropriately. Since most driving tests use measured values, such as SDLP, the test-retest reliability verifies temporal as opposed to inter-rater reliability. In ORT, as well as in the WURT, the testretest reliability of SDLP is confirmed by conducting an HDT in the morning and afternoon. On the other hand, reliability cannot be confirmed in DS.
Validation
Regarding validity, the effect of the legal limit of alcohol on driving skills is used as a standard. In many countries, a blood alcohol concentration (BAC) of 0.05% is regarded as the legal limit. Although it is necessary to confirm that driving skills decline as BAC increases, an association between BAC and SDLP measured in HDT has been established. An increase of 2.4 cm over the average SDLP is known to be equivalent to a BAC of 0.05%. 139 An epidemiologic study examining the relation between alcohol consumption and traffic accidents found that the risk of an accident doubles when the BAC is over 0.05%. 140 This value was calibrated 30 years ago, and has recently been verified and reconfirmed. 141 In an HDT, three BAC -0.05%, 0.08%, and 0.1% -have been studied. The results of two studies that examined the effects of alcohol in a car-following test differed. 142, 143 Although the effects of alcohol have been verified in other ORT and vehicle-handling tests, the details remain unclear. 144 Validity can be verified with positive controls by clearly detecting the effects that reduce driving skills. 30, 107 Validity has been verified in HDT with zopiclone, which is the most well-known positive control.
On the other hand, validation with alcohol has been attempted in only four of 36 types of DS. Validity has been verified in the Cognitive Research Corporation's Driving Simulator (CRCDS) Mini-SIM, STISIM, Würzburg Institute for Traffic Sciences DS, and York DS. [145] [146] [147] [148] However, the BAC varies, which means that the setting is not unified. In both ORT and DS, the evaluation index validated with alcohol is basically SDLP; the other evaluation items have not been validated.
Influence of drugs on driving performance
On the whole, BZD receptor agonists except for zaleplon 33, 35 had a detrimental effect on driving performance, especially road-tracking performance, in healthy controls. Hypnotics with different mechanisms of action, such as ramelteon 24 and suvorexant, 16 can also impair driving performance in healthy controls. Anxiolytics with different mechanisms of action, such as buspirone 97 and tandospirone, 75 may not have an adverse influence on driving performance. As for antidepressants, sedative antidepressants, such as amitriptyline 79, 80 and mirtazapine 18, 72, 73 had negative impacts on overall driving performance in the acute administration while non-sedative antidepressants, such as SSRI 80, 82 and SNRI, 40 did not have a significant effect. Other psychotropics, such as antipsychotics, 109 mood stabilizers,119 and anticonvulsants, have not been examined sufficiently, and those effects on driving performance remain inconclusive. The adverse influences of psychotropics on driving performance may rely on evaluating time after acute administration 21, 23 and psychotropic dosage 25, 50, 109 and those negative effects may also reduce as tolerance develops under continuous administration. 107, 120 However, the influence of long-term treatment is unknown since durations of most studies were fixed for a few days or weeks. In addition, the effects of psychotropics on driving performance in patients differed from those in healthy controls. 107, 110, 111 A sedative antidepressant, mirtazapine, improved driving performance of patients with major depression even in acute administration and effects on driving performance varied among antipsychotics in patients with schizophrenia.
110,111
DISCUSSION
We conducted a review to analyze the evaluation methods for the effects of psychotropics on driving performance. As mentioned above, although a few evaluation methods exist for analyzing driving performance, these have not been standardized among research facilities. Over the past decade, ORT and DS have been used at about the same frequency, but the number of studies using DS is gradually increasing. Most ORT are carried out in the Netherlands, which means that laboratory tests are increasing worldwide. Recently, flibanserin was approved by the FDA after its safety was confirmed using a DS 149 thus, DS may be used much more frequently in the near future. The only method that has been standardized and verified in terms of its reliability and validity is HDT, and the only evaluation index that has been established is SDLP. However, almost all the subjects in the reviewed studies were young healthy subjects, and the drugs examined were mostly limited to hypnotics and antidepressants.
HDT in ORT is the gold standard of driving skill evaluations because its method has been established, verified, and standardized. However, it has only been standardized on highways in the Netherlands. Since the characteristics of highways vary in each country, it is practically impossible to standardize such tests around the world. Furthermore, the high economic costs and requirements for careful consideration of safety and ethical issues are big problems of HDT in ORT. On the other hand, DS have economic and safety advantages. For example, DS can evaluate the DCV, which was difficult to measure in ORT, and their reproducibility is guaranteed because they are not affected by weather or traffic conditions. However, in DS, the equipment, scenarios, test times, and evaluation indices have not been unified, so each research laboratory uses its own standard. A number of different scenarios are described, and it is therefore impossible to compare the results between different DS directly. For further research, scenarios and measurement indices need to be standardized to some extent.
Another problem of DS is motion sickness, which may affect measurements or interrupt the test. However, some studies have reported that this does not affect measurements because a fear of motion sickness leads to more careful driving, 150 and motion sickness is affected by a variety of factors (e.g., sleep deprivation, hunger, mental conditions such as stress, and aging). 151 Therefore, it is necessary to make adjustments that can prevent or minimize motion sickness in the DS laboratory environment. Furthermore, if the drug used as a positive control can relieve sickness, it may be difficult to interpret the result.
Because indices similar to SDLP have been established as indicators in HDT used in DS, SDLP may be the index with the greatest degree of consensus. However, the SDLP value differs between ORT and DS, and also among DS, so this value cannot be compared directly. It is only in ORT that an increased SDLP of 2.4 cm corresponds to a BAC of 0.05%. Generally, the SDLP tends to be higher, and individual variation tends to be larger, in DS, 152 which may be due to difference in the shape of the course or the DS measurement environment. This suggests the possibility that not being accustomed to DS leads to a lack of steering cues and feedback and reckless driving owing to the failure to recognize dangers. SDS and ILC, which are measured secondarily to SDLP, are used without consensus. Although SDLP is the gold standard, this does not mean that all driving skills can be evaluated independently. However, SDLP is known to be a more sensitive evaluation parameter than SDS, and to reflect the risk of traffic accidents indirectly. 153 On the other hand, considering that many traffic accidents are collisions, DCV, which is the CV of the inter-vehicular distance, may be a more predictable factor. In addition, because it is a measured value in DS, it is a highly safe and accurate evaluation parameter. In the future, it will be necessary to rely not only on SDLP, which evaluates one aspect of driving, but also on other highly useful measurements that are strongly associated with traffic accidents.
Although reliability has been verified with testretest reliability in HDT, 58, 137 it has not in other tests in ORT. Examinations in ORT, such as the WURT 106 or WAFAB, 104 in which the passenger evaluates the driver, must not vary between examiners to confirm inter-rater reliability. In DS, it is desirable to confirm test-retest reliability by setting an appropriate task time in accordance with the CV value.
It is difficult to say that verifying test validity of DS is sufficient as follows. HDT in ORT has been verified, but in DS, only four tests (e.g., CRCDS Mini-Sim, STIMSIM DS, Würzburg Institute for Traffic Sciences DS, and York DS) have confirmed validity.
145-148 Validation with alcohol is needed for each method before interpreting the results from DS. Although many examinations have used a BAC of 0.05% or more based on European legal standards, verification is needed in accordance with the legal limits in each country (e.g., 0.03% in Japan). It is also desirable to examine differences between races when validating BAC. Many of the participants in the European study were Caucasians, who have strong aldehyde dehydrogenase enzyme (ALDH2) activity because of their genetic background. Because many East Asians, including Japanese, have weak ALDH2 activity, 154 it is desirable to conduct an alcohol patch test or to genotype the ALDH2 gene before carrying out research.
The effects of medications on patients remain unclear because almost all experiments were conducted with healthy subjects. With healthy subjects, the effect size might be exaggerated because there are no therapeutic effects. Furthermore, it is better to distinguish the acute and chronic phases in such patients. It is also difficult to say whether the effects of age and sex have been fully accounted for. Although healthy young men were included in many of the examinations, it should be taken into consideration that hypnotics and antidepressants are prescribed in many elderly patients, and that some psychotic disorders, such as depression, have sex differences. Despite many reports 38, 155 that have shown a close association between medical and psychiatric disorders and traffic accidents, few have considered comorbidities and concomitant drugs. The HDT as the gold standard method is limited because it has only been standardized on Dutch highways and cannot be employed worldwide. Thus, the DS may have the advantage of ease of validation worldwide with consideration for ethnicity, including ALDH genotype. Considering that the number of experiments for elderly people and patients is expected to increase, DS will likely become the mainstream from the aspect of safety and economics. DS will have a growing role in the evaluation of the effect of medication on driving performance and future studies should verify the effect of various drugs on driving performance with validated and standardized DS. Although validation study with alcohol is indispensable, DS should have both standardized commonalities in comparison between different DS and regional identities reflecting each traffic condition. Researchers, physicians, pharmaceutical companies, and governments should cooperate to develop standardized DS and guidelines for DS.
Conclusion
HDT have traditionally been the gold standard for evaluating the effects of psychotropic drugs on driving performance. As described in FDA-approved materials, DS will gradually play a much greater role. The SDLP is the only currently validated index, and the most frequently used. However, regardless of the method used, validation with alcohol is needed before interpreting the results. To further advance the research in this area, standardized conditions, such as scenarios or experimental environments, are needed to accumulate evidence with valid and reliable DS in each research facility.
